Y
Yasuni Nakanuma
Researcher at Kanazawa University
Publications - 840
Citations - 45311
Yasuni Nakanuma is an academic researcher from Kanazawa University. The author has contributed to research in topics: Primary biliary cirrhosis & Bile duct. The author has an hindex of 94, co-authored 828 publications receiving 41738 citations. Previous affiliations of Yasuni Nakanuma include Nagasaki University.
Papers
More filters
Journal ArticleDOI
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
Fernando Alvarez,P.A. Berg,Francesco B. Bianchi,Leonardo Bianchi,A.K. Burroughs,Eduardo Luiz Rachid Cançado,Roger W. Chapman,W. G. E. Cooksley,Albert J. Czaja,V J Desmet,Peter T. Donaldson,A. L. W. F. Eddleston,L. Fainboim,Jenny Heathcote,Jean-Claude Homberg,Jay H. Hoofnagle,Shinichi Kakumu,Edward L. Krawitt,Ian R. Mackay,R. N. M. Macsween,Willis C. Maddrey,Michael P. Manns,I.G. McFarlane,K H Meyer zum Büschenfelde,G. Mieli-Vergani,Yasuni Nakanuma,Mikio Nishioka,Edward Penner,Gilda Porta,Bernard Portmann,W. D. Reed,Joan Rodés,Solko W. Schalm,P. J. Scheuer,Erik Schrumpf,Takeshi Seki,Gotaro Toda,Takao Tsuji,Niels Tygstrup,Diego Vergani,Mikio Zeniya +40 more
Journal ArticleDOI
Consensus statement on the pathology of IgG4-related disease
Vikram Deshpande,Yoh Zen,John Kc Chan,Eunhee E Yi,Yasuharu Sato,Tadashi Yoshino,Günter Klöppel,J. Godfrey Heathcote,Arezou Khosroshahi,Judith A. Ferry,Rob C. Aalberse,Daniel Bloch,William R. Brugge,Adrian C Bateman,Mollie N. Carruthers,Suresh T. Chari,Wah Cheuk,Lynn D. Cornell,Carlos Fernandez-del Castillo,David G. Forcione,Daniel L. Hamilos,Terumi Kamisawa,Satomi Kasashima,Shigeyuki Kawa,Mitsuhiro Kawano,Gregory Y. Lauwers,Yasufumi Masaki,Yasuni Nakanuma,Kenji Notohara,Kazuichi Okazaki,Ji Kon Ryu,Takako Saeki,Dushyant V. Sahani,Thomas C. Smyrk,James Robert Stone,Masayuki Takahira,George Webster,Motohisa Yamamoto,Giuseppe Zamboni,Hisanori Umehara,John H. Stone +40 more
TL;DR: This statement proposes a terminology scheme for the diagnosis of IgG4-related disease that is based primarily on the morphological appearance on biopsy, and advocates the use of strict criteria for accepting newly proposed entities or sites as components of the IgG 4- related disease spectrum.
Journal ArticleDOI
Prospective Cohort Study of Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma in 8510 Patients
Kenichi Takayasu,Shigeki Arii,Iwao Ikai,Masao Omata,Kiwamu Okita,Takafumi Ichida,Yutaka Matsuyama,Yasuni Nakanuma,Masamichi Kojiro,Masatoshi Makuuchi,Yoshio Yamaoka +10 more
TL;DR: TACE showed safe therapeutic modality with a 5-year survival of 26% for unresectable HCC patients and both the degree of liver damage and the tumor-node-metastasis (TNM) system proposed by the Liver Cancer Study Group of Japan demonstrated good stratification of survivals.
Journal ArticleDOI
Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers.
Tania Roskams,Neil D. Theise,Charles Balabaud,Govind Bhagat,Prithi S. Bhathal,Paulette Bioulac-Sage,Elizabeth M. Brunt,James M. Crawford,Heather A. Crosby,Valeer Desmet,Milton J. Finegold,Stephen A. Geller,Annette S. H. Gouw,Prodromos Hytiroglou,A. S. Knisely,Masamichi Kojiro,Jay H. Lefkowitch,Yasuni Nakanuma,John K. Olynyk,Young Nyun Park,Bernard Portmann,Romil Saxena,Peter J. Scheuer,Alastair J. Strain,Swan N. Thung,Ian R. Wanless,A. Brian West +26 more
TL;DR: This international group of liver pathologists and hepatologists seeks to arrive at a consensus on nomenclature for normal human livers and human reactive lesions that can facilitate more rapid advancement of the field.
Journal ArticleDOI
Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis.
Yoh Zen,Takahiko Fujii,Kenichi Harada,Mitsuhiro Kawano,Kazunori Yamada,Masayuki Takahira,Yasuni Nakanuma +6 more
TL;DR: AIPC is a unique inflammatory disorder characterized by an immune reaction predominantly mediated by Th2 cells and Tregs, which could be characterized by the over‐production of T helper (Th) 2 and regulatory cytokines.